2023 General Meeting Results
Released
Released
Announcement PDF
ASX Announcement
9 November 2023
General Meeting Results
Melbourne, Australia, 9 November 2023 – In accordance with ASX Listing Rule 3.13.2 and section
251AA of the Corporations Act 2001 (Cth), Avecho Biotechnology Limited (ASX: AVE) advises that the details
of the resolutions and the proxies received in respect of each resolution at its General Meeting today are set
out in the attached proxy summary.
For enquiries, please contact
Melanie Leydin
Company Secretary
+61 3 9692 7222
This announcement has been authorised by the Board of Directors of Avecho Biotechnology Limited.
About Avecho
Avecho Biotechnology Limited (ASX: AVE) develops and commercialises innovative Human and Animal Health
products using its proprietary drug delivery system called TPM®. TPM® is derived from Vitamin E using
unique, proprietary and patented processes and is proven to enhance the solubility and oral, dermal and
transdermal absorption of drugs and nutrients.
Avecho’s major projects include delivering TPM® enhanced injectable, oral and topical products for the
human health market and is also developing TPM® to enhance the feed efficiency and health of livestock.
New additions to the development program include the recently announced application of TPM® to
cannabinoids.
See more here - avecho.com.au
Avecho Biotechnology Limited | ASX:AVE | ACN: 056 482 403 | ABN: 32 056 482 403
Unit 8A, 2A Westall Road, Hallmarc Business Park, Clayton VIC Australia 3168
avecho.com.au
2023 General Meeting
Thursday 9 November 2023
Voting Results
The following information is provided in accordance with section 251AA(2) of Corporations Act 2001 (Cth) and ASX Listing Rule 3.13.2.
Show of
Hands
(S) or
Poll (P)
Resolution Details
Resolution
Resolution
Type
If
s259U
applies
S or P
1
Ratification of prior issue
of Shares
Ordinary
N/A
P
2
Approval to issue Shares
Ordinary
N/A
P
3
Approval to issue New
Options
Ordinary
N/A
P
4(a)
Approval to issue Shares
and New Options to Mr
Matthew
Patrick
McNamara
(or
his
nominee)
Ordinary
N/A
P
4(b)
Approval to issue Shares
and New Options to Dr
Gregory Collier (or his
nominee)
Ordinary
N/A
P
5
Approval to issue Broker
Options
Ordinary
N/A
P
Instructions given to validly appointed proxies
(as at proxy close)
For
Against
Proxy’s
Discretion
Abstain
140,303,453
4,374,328
3,167,956
94.90%
2.96%
2.14%
137,488,005
9,976,828
91.27%
6.63%
130,329,397
Number of votes cast on the poll
(where applicable)
For
Against
Abstain
14,516,763
156,905,583
4,374,328
14,516,763
-
97.29%
2.71%
-
3,167,956
14,516,763
154,090,135
9,976,828
14,516,763
2.10%
-
93.92%
6.08%
-
10,039,053
3,252,456
14,748,646
147,016,027
10,039,053
14,748,646
90.74%
6.99%
2.27%
-
93.61%
6.39%
-
151,318,022
13,165,108
3,175,695
93,386,350
167,927,891
13,165,108
93,386,350
90.25%
7.85%
1.90%
-
92.73%
7.27%
-
236,837,662
18,369,663
3,047,123
6,790,727
253,318,959
18,369,663
6,790,727
91.70%
7.12%
1.18%
-
93.24%
6.76%
-
235,995,413
9,271,361
3,192,956
16,585,445
252,622,543
9,271,361
16,585,445
94.98%
3.73%
1.29%
-
96.46%
3.54%
-
Resolution
Result
Carried/
Not
Carried
Carried
Carried
Carried
Carried
Carried
Carried
*Votes cast by a person who abstains on an item are not counted in calculating the required majority on a poll.
Avecho Biotechnology Limited | ASX:AVE | ACN: 056 482 403 | ABN: 32 056 482 403
Unit 8A, 2A Westall Road, Hallmarc Business Park, Clayton VIC Australia 3168
avecho.com.au
Share your feedback
Discover